메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
이민종 (강원대학교병원)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.34 No.30
발행연도
2019.1
수록면
1 - 2 (2page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Kim et al.1 recently reported that partial splenic embolization (PSE) had good safety and efficacy to increase platelet counts in hepatocellular carcinoma (HCC) patients with thrombocytopenia who underwent trans-arterial chemoembolization (TACE). In this study, 18 HCC patients with severe thrombocytopenia (< 50 × 109 /L) who underwent PSE concurrently with TACE (PSE group) and 72 controls who underwent TACE alone (non-PSE group) were enrolled. Regarding efficacy of PSE, platelet counts in the PSE group were significantly increased compared with those in the non-PSE group. Splenic infarction rates were significantly associated with increase in platelet counts after PSE with the median splenic infarction rates of 77.8%. Regarding safety of PSE in this study, the Child-Turcotte-Pugh scores within 6 months after treatment in the PSE group were significantly higher than those in the non-PSE-group. However, there was no significant difference of severe adverse events occurred in the two group: 11.1% and 9.7% of patients in the PSE and non-PSE groups, respectively.1

목차

등록된 정보가 없습니다.

참고문헌 (4)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0